Anlotinib Active Not Recruiting Phase 2 / 3 Trials for Differentiated Thyroid Cancer (DTC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs